Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Jul;29(4):315-318.
doi: 10.1097/MOU.0000000000000643.

Somatic and germline sequencing in genitourinary oncology: genetics for the clinician

Jonathan E Shoag  1 , David R Wise  2 , Ravi N Sharaf  3 , Cora N Sternberg  4
Affiliations
Review

Somatic and germline sequencing in genitourinary oncology: genetics for the clinician

Jonathan E Shoag et al. Curr Opin Urol. 2019 Jul.

Abstract

Purpose of review: Next-generation sequencing is becoming more accessible. This review focuses on the clinical application of somatic and germline sequencing to genitourinary oncology.

Recent findings: Germline variants have been increasingly recognized as contributing to the development of genitourinary malignancies, particularly in patients with advanced disease. A variety of commercial and institutional technologies are in use to detect variants, with newer tools focused on integrating these results into the clinical workflow.

Summary: DNA sequencing is becoming a valuable tool in caring for patients with genitourinary malignancies. Performing both somatic and germline sequencing will likely become standard practice. Interpretation and clinical application of these results can be challenging and often requires multidisciplinary expertise.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest

There are no conflicts of interest.

References

    1. NCI. The genetics of cancer. [Accessed 20 February 2019, updated 12 October 2017]
    1. Li MM, Datto M, Duncavage EJ, et al. Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer: a joint consensus recommendation of the association for molecular pathology, American Society of Clinical Oncology, and College of American Pathologists. J Mol Diagn 2017; 19:4–23. - PMC - PubMed
    1. Pritchard CC, Mateo J, Walsh MF, et al. Inherited DNA-repair gene mutations in men with metastatic prostate cancer. N Engl J Med 2016; 375:443–453. - PMC - PubMed

    1. Carlo MI, Mukherjee S, Mandelker D, et al. Prevalence of germline mutations in cancer susceptibility genes in patients with advanced renal cell carcinoma. JAMA Oncol 2018; 4:1228–1235.

      ■ This article highlights the high prevalence of germline mutations in patients with advanced RCC.

    1. Rahman N, Scott RH. Cancer genes associated with phenotypes in monoallelic and biallelic mutation carriers: new lessons from old players. Hum Mol Genet 2007; 16 Spec No 1:R60–6. - PubMed

Publication types

MeSH terms

Substances